SRx Health (SRXH) Solutions announced the closing of a $7.3M convertible note financing, led by insiders and existing investors. Additionally, SRX Health has secured a $50M equity line of credit. This financing and ELOC financial commitment significantly strengthens the Company’s balance sheet and provides additional working capital to advance near-term growth initiatives. The combined proceeds from the financing will be deployed to support SRXH’s acquisition pipeline in the U.S., bolster its Canadian specialty pharma footprint, and invest in next-generation capabilities that enhance patient access and operational efficiency across its core business.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRXH:
- SRx Health Solutions Announces New Leadership Team
- SRx Health Solutions Reports Q1 2025 Earnings
- SRx Health diversifies treasury strategy with purchase of ethereum
- SRx Health diversifies treasury strategy with purchase of bitcoin
- SRx Health announces intention to create crypto-based borrowing subsidiary